Loading...
Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study.
The deprenyl and tocopherol antioxidative treatment (DATATOP) study has shown that selegiline (deprenyl), with or without tocopherol, reduces physical and psychological deficits in patients with Parkinson's disease within one month of treatment and reduces the probability of reaching a primary...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
1994
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1072455/ https://ncbi.nlm.nih.gov/pubmed/8126510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|